"Prazosin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
| Descriptor ID |
D011224
|
| MeSH Number(s) |
D03.633.100.786.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prazosin".
Below are MeSH descriptors whose meaning is more specific than "Prazosin".
This graph shows the total number of publications written about "Prazosin" by people in this website by year, and whether "Prazosin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prazosin" by people in Profiles.
-
Visible and invisible wounds. J Psychiatr Pract. 2009 Nov; 15(6):429.
-
High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther. 2005 Apr; 30(2):173-8.
-
Evidence favoring the use of an alpha2-selective vasopressor agent for cardiopulmonary resuscitation. Circulation. 2003 Nov 25; 108(21):2716-21.
-
Inhibition of glutamatergic synaptic input to spinal lamina II(o) neurons by presynaptic alpha(2)-adrenergic receptors. J Neurophysiol. 2002 Apr; 87(4):1938-47.
-
Functional characterization of alpha1-adrenergic receptors in experimental vein grafts. J Surg Res. 1999 Jun 01; 84(1):40-5.
-
Troponin I phosphorylation in spontaneously hypertensive rat heart: effect of beta-adrenergic stimulation. Am J Physiol. 1997 Sep; 273(3 Pt 2):H1440-51.
-
Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions. Am J Hypertens. 1995 Feb; 8(2):133-45.
-
Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension. J Clin Pharmacol. 1992 Apr; 32(4):351-9.
-
Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials. Am Heart J. 1991 Sep; 122(3 Pt 2):926-31.
-
Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism. Am Heart J. 1991 Jan; 121(1 Pt 2):251-9; discussion 259-60.